Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision entry (v3.4.2) was added. The previous funding-lapse notice (v3.4.1) was removed.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and operating status, and updated the record history to Revision: v3.4.1. The previous Revision: v3.4.0 entry was removed.SummaryDifference0.8%

- Check28 days agoChange DetectedThe history page now includes a glossary option and updated explanations for color-coded changes (green for additions and red for deletions) with a new Revision: v3.4.0. The No FEAR Act data label was adjusted and the previous Revision: v3.3.4 entry was removed.SummaryDifference1.0%

- Check64 days agoChange DetectedAdded a new Revision: v3.3.3 entry to the study history and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and the removal of an earlier revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe history page shows a new site revision label (v3.3.1) replacing v3.2.0, with no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.